Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Edelweiss Business Cycle Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseEdelweissHDFC
NAV₹9.2021₹22.8170
NAV date20 Nov 202620 Nov 2026
History2.3 years3.1 years
Expense ratio2.7%2.1%
StarsNot rated★★★★★
Growth Score—93.90

Returns

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+5.71%+12.87%
3 months+0.80%+6.85%
6 months+4.95%+17.20%
YTD+1.69%+32.43%
1 year+2.20%+30.73%
3 years (CAGR)—+29.16%
5 years (CAGR)——
10 years (CAGR)——
Since launch−3.74%+30.28%

Risk

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility—15.8%
Downside volatility—8.6%
Sharpe—1.44
Sortino—2.64
Calmar—1.94
Return / risk—1.85
Deepest fall−26.91%−15.07%
Days to recover—133
Below its high−10.68%+0.00%

Against benchmark

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha—+6.36%
Beta—0.97
R²—85.0%
Up capture—106.7%
Down capture—74.4%
Tracking error—6.1%
Information ratio—0.97
Treynor—0.22

Consistency

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+19.06%+64.96%
Middle 1-year−0.57%+21.84%
Worst 1-year−16.02%+0.52%
1-year periods with a loss51.7%0.0%
Middle 3-year—+28.68%
Positive months—69.4%
Best day+4.77%+3.19%
Worst day−3.86%−3.62%
Worst 5% day−2.02%−1.50%
Positive days53.1%58.1%
NAVs a year247247

SIP of ₹10,000 a month

Edelweiss Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR—+26.26%
1-year XIRR+7.48%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth